Peter A. Ste‐Marie

1.3k total citations
22 papers, 983 citations indexed

About

Peter A. Ste‐Marie is a scholar working on Pharmacology, Psychiatry and Mental health and General Health Professions. According to data from OpenAlex, Peter A. Ste‐Marie has authored 22 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 17 papers in Psychiatry and Mental health and 4 papers in General Health Professions. Recurrent topics in Peter A. Ste‐Marie's work include Fibromyalgia and Chronic Fatigue Syndrome Research (16 papers), Musculoskeletal pain and rehabilitation (13 papers) and Cannabis and Cannabinoid Research (8 papers). Peter A. Ste‐Marie is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (16 papers), Musculoskeletal pain and rehabilitation (13 papers) and Cannabis and Cannabinoid Research (8 papers). Peter A. Ste‐Marie collaborates with scholars based in Canada, United States and United Kingdom. Peter A. Ste‐Marie's co-authors include Mary‐Ann Fitzcharles, Yoram Shir, Pantelis Panopalis, John X. Pereira, Emmanouil Rampakakis, John S. Sampalis, Manon Choinière, Susan Abbey, Gordon Ko and Don L. Goldenberg and has published in prestigious journals such as Pain, The American Journal of Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

Peter A. Ste‐Marie

22 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter A. Ste‐Marie Canada 16 743 639 167 113 104 22 983
Baltasar Rodero Spain 13 600 0.8× 457 0.7× 169 1.0× 114 1.0× 216 2.1× 15 907
Connie A. Luedtke United States 20 565 0.8× 524 0.8× 123 0.7× 133 1.2× 114 1.1× 43 1.0k
Gordon Ko Canada 12 449 0.6× 399 0.6× 88 0.5× 60 0.5× 43 0.4× 20 716
Patrick Welsch Germany 16 457 0.6× 312 0.5× 132 0.8× 52 0.5× 76 0.7× 25 750
Janet Erro United States 11 529 0.7× 170 0.3× 295 1.8× 82 0.7× 162 1.6× 12 1.1k
H. Kühn-Becker Germany 14 444 0.6× 557 0.9× 81 0.5× 113 1.0× 89 0.9× 19 644
David K. Chatkoff United States 8 521 0.7× 204 0.3× 209 1.3× 95 0.8× 147 1.4× 13 766
E. Neubauer Germany 16 436 0.6× 220 0.3× 113 0.7× 48 0.4× 47 0.5× 31 607
S Clark United States 13 498 0.7× 635 1.0× 116 0.7× 92 0.8× 80 0.8× 15 1.1k
D. Turk United States 9 288 0.4× 324 0.5× 91 0.5× 47 0.4× 44 0.4× 14 535

Countries citing papers authored by Peter A. Ste‐Marie

Since Specialization
Citations

This map shows the geographic impact of Peter A. Ste‐Marie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Ste‐Marie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Ste‐Marie more than expected).

Fields of papers citing papers by Peter A. Ste‐Marie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Ste‐Marie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Ste‐Marie. The network helps show where Peter A. Ste‐Marie may publish in the future.

Co-authorship network of co-authors of Peter A. Ste‐Marie

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Ste‐Marie. A scholar is included among the top collaborators of Peter A. Ste‐Marie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Ste‐Marie. Peter A. Ste‐Marie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ablin, Jacob N., Peter A. Ste‐Marie, Michael Schäfer, Winfried Häuser, & Mary‐Ann Fitzcharles. (2016). Medical use of cannabis products. Der Schmerz. 30(1). 3–13. 47 indexed citations
2.
Fitzcharles, Mary‐Ann, Peter A. Ste‐Marie, Emmanouil Rampakakis, John S. Sampalis, & Yoram Shir. (2016). Disability in Fibromyalgia Associates with Symptom Severity and Occupation Characteristics. The Journal of Rheumatology. 43(5). 931–936. 22 indexed citations
3.
Ste‐Marie, Peter A., Yoram Shir, Emmanouil Rampakakis, et al.. (2016). Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis. Pain. 157(12). 2792–2797. 40 indexed citations
4.
Rampakakis, Emmanouil, et al.. (2015). Real-life assessment of the validity of patient global impression of change in fibromyalgia. RMD Open. 1(1). e000146–e000146. 85 indexed citations
5.
Fitzcharles, Mary‐Ann, Peter A. Ste‐Marie, Winfried Häuser, et al.. (2015). Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials. Arthritis Care & Research. 68(5). 681–688. 60 indexed citations
6.
Fitzcharles, Mary‐Ann, Peter A. Ste‐Marie, Yoram Shir, & David Lussier. (2014). Management of Fibromyalgia in Older Adults. Drugs & Aging. 31(10). 711–719. 9 indexed citations
7.
Fitzcharles, Mary‐Ann, Peter A. Ste‐Marie, Angela Mailis, & Yoram Shir. (2014). Adjudication of Fibromyalgia Syndrome: Challenges in the Medicolegal Arena. Pain Research and Management. 19(6). 287–292. 6 indexed citations
8.
Fitzcharles, Mary‐Ann, Emmanouil Rampakakis, Peter A. Ste‐Marie, John S. Sampalis, & Yoram Shir. (2014). The Association of Socioeconomic Status and Symptom Severity in Persons with Fibromyalgia. The Journal of Rheumatology. 41(7). 1398–1404. 50 indexed citations
9.
Fitzcharles, Mary‐Ann, Peter A. Ste‐Marie, Daniel J. Clauw, et al.. (2014). Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints. BMC Musculoskeletal Disorders. 15(1). 258–258. 48 indexed citations
10.
Fitzcharles, Mary‐Ann, Emmanouil Rampakakis, Peter A. Ste‐Marie, John S. Sampalis, & Yoram Shir. (2014). THU0318 Real-Life Assessment of the Validity of Patient Global Impression of Change in Fibromyalgia. Annals of the Rheumatic Diseases. 73. 292–292. 1 indexed citations
11.
Fitzcharles, Mary‐Ann, Peter A. Ste‐Marie, Don L. Goldenberg, et al.. (2013). 2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome: Executive Summary. Pain Research and Management. 18(3). 119–126. 297 indexed citations
12.
Fitzcharles, Mary‐Ann, Peter A. Ste‐Marie, Don L. Goldenberg, et al.. (2013). Canadian Pain Society and Canadian Rheumatology Association Recommendations for Rational Care of Persons with Fibromyalgia. A Summary Report. The Journal of Rheumatology. 40(8). 1388–1393. 35 indexed citations
13.
Fitzcharles, Mary‐Ann, Peter A. Ste‐Marie, & John X. Pereira. (2013). Fibromyalgia: evolving concepts over the past 2 decades. Canadian Medical Association Journal. 185(13). E645–E651. 25 indexed citations
14.
Fitzcharles, Mary‐Ann, Peter A. Ste‐Marie, & Yoram Shir. (2013). A Medicolegal Analysis of Worker Appeals for Fibromyalgia as a Compensable Condition Following Workplace Soft-tissue Injury. The Journal of Rheumatology. 40(3). 323–328. 7 indexed citations
15.
Fitzcharles, Mary‐Ann, Neda Faregh, Peter A. Ste‐Marie, & Yoram Shir. (2013). Opioid Use in Fibromyalgia Is Associated with Negative Health Related Measures in a Prospective Cohort Study. Pain Research and Treatment. 2013. 1–7. 51 indexed citations
16.
Fitzcharles, Mary‐Ann, Jason J. McDougall, Peter A. Ste‐Marie, & Ivan Padjen. (2012). Clinical implications for cannabinoid use in the rheumatic diseases: Potential for help or harm?. Arthritis & Rheumatism. 64(8). 2417–2425. 14 indexed citations
17.
Fitzcharles, Mary‐Ann, Peter A. Ste‐Marie, Pantelis Panopalis, et al.. (2012). The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort. BMC Musculoskeletal Disorders. 13(1). 179–179. 40 indexed citations
18.
Ste‐Marie, Peter A., Mary‐Ann Fitzcharles, Ann Gamsa, Mark A. Ware, & Yoram Shir. (2012). Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia. Arthritis Care & Research. 64(8). 1202–1208. 22 indexed citations
19.
Fitzcharles, Mary‐Ann, Peter A. Ste‐Marie, Don L. Goldenberg, et al.. (2012). 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome. 26 indexed citations
20.
Fitzcharles, Mary‐Ann, Peter A. Ste‐Marie, Ann Gamsa, Mark A. Ware, & Yoram Shir. (2011). Opioid Use, Misuse, and Abuse in Patients Labeled as Fibromyalgia. The American Journal of Medicine. 124(10). 955–960. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baltasar Rodero Breakdown of academic impact, for papers by Connie A. Luedtke Breakdown of academic impact, for papers by Gordon Ko Breakdown of academic impact, for papers by Patrick Welsch Breakdown of academic impact, for papers by Janet Erro Breakdown of academic impact, for papers by H. Kühn-Becker Breakdown of academic impact, for papers by David K. Chatkoff Breakdown of academic impact, for papers by E. Neubauer Breakdown of academic impact, for papers by S Clark Breakdown of academic impact, for papers by D. Turk
Rankless by CCL
2026